tadalafil has been researched along with Obesity in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Barocio-Pantoja, M; Cardona-Müller, D; Cardona-Muñoz, EG; González-Radillo, OI; Grover-Páez, F; Larios-Cárdenas, M; Trujillo-Quirós, J | 1 |
| Antunes, E; de Gomes, ET; de Oliveira, MG; Leonardi, GR; Mónica, FZ; Passos, GR; Zapparoli, A | 1 |
| Dal Moro, F; Livi, U; Vendramin, I | 1 |
| Jansson, PA; Lönnroth, P; Sandqvist, M; Strindberg, L | 1 |
| Arora, P; Buys, ES; Dhakal, BP; Florez, JC; Ghorbani, A; Guanaga, DP; Ho, JE; Lewis, GD; Nathan, DI; Newton-Cheh, C; Walford, GA; Wang, TJ | 1 |
| González-Ortiz, M; Hernández-Corona, DM; Martínez-Abundis, E; Ramírez-Rodríguez, AM | 1 |
| Das, A; Durrant, DE; Hoke, NN; Kukreja, RC; Salloum, FN; Varma, A | 1 |
4 trial(s) available for tadalafil and Obesity
| Article | Year |
|---|---|
Tadalafil Improves Haemodynamics and Arterial Stiffness but Not Flow- Mediated Dilation in Grade 1 Obesity. A Single-dose, Placebo-controlled Clinical Trial.
Topics: Ankle Brachial Index; Blood Pressure; Dilatation; Double-Blind Method; Hemodynamics; Humans; Obesity; Pulse Wave Analysis; Tadalafil; Vascular Stiffness | 2022 |
Decreased permeability surface area for glucose in obese women with postprandial hyperglycemia: no effect of phosphodiesterase-5 (PDE-5) inhibition.
Topics: Aged; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Glucose; Humans; Hyperglycemia; Middle Aged; Obesity; Permeability; Phosphodiesterase Inhibitors; Postprandial Period; Tadalafil; Treatment Outcome | 2013 |
Effect of phosphodiesterase inhibition on insulin resistance in obese individuals.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Boston; Carbolines; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Phosphodiesterase 5 Inhibitors; Pilot Projects; Severity of Illness Index; Tadalafil; Time Factors; Treatment Outcome; Young Adult | 2014 |
Effect of tadalafil administration on insulin secretion and insulin sensitivity in obese men.
Topics: Adult; Double-Blind Method; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Phosphodiesterase 5 Inhibitors; Tadalafil | 2017 |
3 other study(ies) available for tadalafil and Obesity
| Article | Year |
|---|---|
Inhibition of multidrug resistance proteins by MK571 restored the erectile function in obese mice through cGMP accumulation.
Topics: Acetylcholine; Animals; ATP Binding Cassette Transporter, Subfamily B; Cyclic GMP; Erectile Dysfunction; Humans; Male; Mice; Mice, Obese; Nitroprusside; Obesity; Tadalafil | 2023 |
The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?
Topics: Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Estrogens; Humans; Hypertension; Inflammation; Interleukins; Models, Animal; Models, Biological; Nitric Oxide; Obesity; Off-Label Use; Pandemics; Peptidyl-Dipeptidase A; Phosphodiesterase 5 Inhibitors; Pneumonia, Viral; Receptors, Virus; SARS-CoV-2; Sildenafil Citrate; Tadalafil | 2020 |
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Experimental; Drug Administration Schedule; Fasting; Interleukin-1beta; Male; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necrosis; Obesity; Phosphodiesterase Inhibitors; Receptors, Leptin; Tadalafil; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |